iShares Nasdaq US Biotech ETF USD Dist (LSE:BTEE) - ETF price


ETF Report

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) BTEE

Closing Price
USD4.72

1 Day Change
0.00|0.00%

As of 14/06/2019

Last Close4.72
52-Wk Range4.50 - 5.58
Yield %0.07
ISINIE00BDZVHG35
Volume7,168
Premium %0.46

Growth Of 10,000 (USD) 31/05/2019

HowHasThisSecurityPerformed
201420152016201720182019
Fund-----5.38
Category-----6.55
Benchmark-----3.34
  • Fund: iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
  • Category: Sector Equity Biotechnology
  • Benchmark: NASDAQ Biotechnology TR USD
Trailing Returns % (USD) 14/06/2019
FundCatBmark
YTD8.1711.656.62
3 Years Annualised---
5 Years Annualised---
10 Years Annualised---
Key Stats
Morningstar® CategorySector Equity Biotechnology
ISINIE00BDZVHG35
NAV 14/06/2019USD 4.72
Day Change0.00%
12 Month Yield0.07%
Dividend FrequencySemi-Annually
Net Assets (mil) 13/06/201929.20 USD
Total Expense Ratio0.35%
Initial Charge-
Exit Charge-
Manager Name-
Inception Date05/03/2018

Morningstar Rating™

Not Rated

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Benchmarks

Fund Benchmark

NASDAQ Biotechnology NR USD

Morningstar® Benchmark

NASDAQ Biotechnology TR USD

Investment Objective

The Fund seeks to track the performance of the NASDAQ Biotechnology Index (Net Total Return) .

Portfolio Profile13/06/2019

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
Gilead Sciences Inc Healthcare8.88
Celgene Corp Healthcare8.87
Amgen Inc Healthcare8.01
Biogen Inc Healthcare5.96
Vertex Pharmaceuticals Inc Healthcare5.65
Asset Allocation %
LongShortNet
Stocks99.880.0099.88
Bonds0.000.000.00
Cash0.120.000.12
Other0.000.000.00
Top Stock Regions
Region%
United States94.85
United Kingdom2.05
Asia - Emerging1.27
Eurozone0.98
Europe - ex Euro0.38
Top Stock Sectors
Stock Sectors%
Healthcare99.96
Basic Materials0.04
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.